Personalized treatments are exactly what they say. It is a relatively new focus on medicine that goes for that particular patient. The drugs are tailored for each person's individual brain tumor. This is when it is referred to as individualized medicine.
Personalized medicine is not only a benefit for the patient, but also for cost of treatments. It is predicted by Edward Abrahams, president of the Personalized Medicine Coalition, that expenses will be cut. He says that researchers will use patient and tumor genomes for new therapies.
Maurie Markman, MD, said the following in an article on Health Leaders Media:
"The future is here," Markman says, noting that there have been gradual and significant cost reductions for genome sequencing over the past decade or so. "Within the next year, it will be possible to sequence the entire genome of a tumor and the corresponding normal genome of an individual cancer patient for $3,000. Twelve to 15 years ago, it would cost about $6 million."
Cantlupe, Joe. "Personalized Cancer Treatments Approach Tipping Point." Health Leaders Media. Health Leaders Media, 27 Sept 2012. Web. 18 Feb 2013. <http://www.healthleadersmedia.com/page-1/LED-284870/Personalized-Cancer-Treatments-Approach-Tipping-Point##>